Italy· 044558031
ENTRESTO*56 cpr rivestite 49 mg + 51 mg
A valsartan and sacubitril product containing sacubitril/valsartan, registered in Italy by NOVARTIS EUROPHARM LTD, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Valsartan and sacubitril is registered in 15 of 19 countries.
Countries holding a registration under ATC C09DX04 (valsartan and sacubitril), each read from that country’s own register.
- This record: Italy
- 9 of them publish a price we can compare per daily dose
Valsartan and sacubitril · ATC C09DX04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Active substance
- Sacubitril/Valsartan
- Manufacturer
- NOVARTIS EUROPHARM LTD
- Country
- Italy (IT)
- ATC code
- C09DX04
- ATC class
- Valsartan and sacubitril
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic044558031ENTRESTO*56 cpr rivestite 49 mg + 51 mgEUR 201.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
8 interactions on record for valsartan and sacubitril.
Graded by severity as the source publishes them — 8 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valsartan and sacubitril · interactions on record
8 records
- 8 moderate
Most severe, free to view
- NitisinoneA16AX04moderate
- SimvastatinC10AA01moderate
- RosuvastatinC10AA07moderate
- Darunavir and cobicistatJ05AR14moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valsartan and sacubitril in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e42d6ff2-5b03-4bf5-8659-50da615ae63d GET /v1/drugs/e42d6ff2-5b03-4bf5-8659-50da615ae63d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 201.94,
"source": "aifa",
"currency": "EUR",
"strength": "SACUBITRIL+VALSARTAN 49+51MG 56 UNITA' USO ORALE",
"substance": "Sacubitril/Valsartan",
"equivalence_group": "HPT",
"transparency_flag": null
}See everything about valsartan and sacubitril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.